Adherex Technologies, Inc.
Cancer therapeutics company reports loss of $0.03 per share
Published in Healthcare Mergers, Acquisitions and Ventures Week, March 27th, 2004
"This past quarter proved to be of great significance for our company," said William Peters, MD, PhD, MBA, CEO, and vice chairman of Adherex. "We successfully raised $23.5 million in new financings and converted a $3 million bridge loan to equity, allowing us to begin 2004 with the resources necessary to move our drug development programs forward aggressively."
The company attracted a number of prominent new investors as part of its $21.5 million private placement that it completed in December. The lead investor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abgenix, Inc.
Biotech company reports loss of $0.60 per share - Able Laboratories, Inc.
FDA approves methamphetamine hydrochloride; company reports financials - Access Pharmaceuticals, Inc.
Pharmaceutical company completes $9.7M private placement - Advanced Medical Optics, Inc.
Ophthalmic device firm reports 13.5% increase in revenue - Aequitas
New biopharmaceutical index published - AlgoRx Pharmaceuticals, Inc.
Pain drug developer raises $65M in series C financing - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
